<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://hboevidence.wikis.unsw.edu.au/index.php?action=history&amp;feed=atom&amp;title=Naibogllu</id>
	<title>Naibogllu - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://hboevidence.wikis.unsw.edu.au/index.php?action=history&amp;feed=atom&amp;title=Naibogllu"/>
	<link rel="alternate" type="text/html" href="http://hboevidence.wikis.unsw.edu.au/index.php?title=Naibogllu&amp;action=history"/>
	<updated>2026-10-04T16:29:09Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.31.0</generator>
	<entry>
		<id>http://hboevidence.wikis.unsw.edu.au/index.php?title=Naibogllu&amp;diff=1155&amp;oldid=prev</id>
		<title>M.bennett at 05:53, 30 September 2021</title>
		<link rel="alternate" type="text/html" href="http://hboevidence.wikis.unsw.edu.au/index.php?title=Naibogllu&amp;diff=1155&amp;oldid=prev"/>
		<updated>2021-09-30T05:53:19Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;http://hboevidence.wikis.unsw.edu.au/index.php?title=Naibogllu&amp;amp;diff=1155&amp;amp;oldid=170&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>M.bennett</name></author>
		
	</entry>
	<entry>
		<id>http://hboevidence.wikis.unsw.edu.au/index.php?title=Naibogllu&amp;diff=170&amp;oldid=prev</id>
		<title>Gordoben: Imported from Wikispaces</title>
		<link rel="alternate" type="text/html" href="http://hboevidence.wikis.unsw.edu.au/index.php?title=Naibogllu&amp;diff=170&amp;oldid=prev"/>
		<updated>2018-06-17T01:57:31Z</updated>

		<summary type="html">&lt;p&gt;Imported from Wikispaces&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;'''&amp;lt;span style=&amp;quot;font-size: 16pt;&amp;quot;&amp;gt;No additional improvement with the addition of intratympanic steroid to systemic steroid &amp;amp; hyperbaric oxygen treatment for sudden hearing loss &amp;lt;/span&amp;gt;'''&lt;br /&gt;
{| &lt;br /&gt;
| &amp;lt;span style'''&amp;quot;font-size: 130%;&amp;quot;&amp;gt;1. Overall both groups improved in terms of pure tone average measurement by the end of the study but there was no difference between groups.&amp;lt;/span&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 130%;&amp;quot;&amp;gt;2. In the subgroup of patients with profound hearing loss, those in the intratympanic steroid group may do better.&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;'''Citation/s:''' 1. Naibogllu B, Külekçi S, Sürmeli M, Verim A, Ertugay CK, Ýhvan O, Seneldir L, SZ Toros. Efficacy of multimodality approach to sudden hearing loss. The Turkish Journal of Ear, Nose and Throat. 2015; 25(2):77-81.&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; '''Lead author's name and email:''' Dr Onder Yhvan, onderihvan@yahoo.com &amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;'''Three-part Clinical Question:''' Does the addition of intratympanic steroid to systemic steroid &amp;amp; hyperbaric oxygen treatment improve the outcome of sudden hearing loss? &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; '''Search Terms:''' Hearing loss, steroid, intratympanic&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;The Study: &amp;lt;/span&amp;gt;'''&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Non-blinded randomised controlled trial with intention-to-treat.&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; '''The Study Patients:''' Patients presenting within 72 hours idiopathic hearing loss of at least 30dB over 3 contiguous test frequencies over 3 days. &amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Control group (N = 20; 20 analysed): Oral prednisone starting at 1mg/kg tapering over 14 days plus hyperbaric oxygen therapy (2.5atm for 90 minutes) once daily for 10 days&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Experimental group (N = 38; 38 analysed): As above plus 3 intratympanic doses of 40mg prednisone commencing at the start of hyperbaric treatment and 3 days apart for subsequent doses.&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size: 11pt;&amp;quot;&amp;gt;The Evidence:&amp;lt;/span&amp;gt;'''&lt;br /&gt;
{| &lt;br /&gt;
! &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Outcome&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; !! &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Time to Outcome&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; !! &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Control group&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; !! &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Intra-tymp. group&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; !! &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Relative risk reduction&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; !! &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Absolute risk reduction&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; !! &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;NNT&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;'''&amp;lt;span style'''&amp;quot;font-size: 12pt;&amp;quot;&amp;gt;Complete recovery by Siegel's Criteria&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;1 month&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;0.30&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;0.29&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;4%&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;0.01&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;91&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|^   |||||| &amp;lt;span style'''&amp;quot;display: block; text-align: right;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;95% CIs:&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;-79% to 86%&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;-0.24 to 0.26&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; || &amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;NNT ''' 4 to INF; &amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;br&amp;gt;&amp;lt;span style'''&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style'''&amp;quot;font-size: 120%;&amp;quot;&amp;gt;NNH ''' 4 to INF&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;Comments:&amp;lt;/span&amp;gt;'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; 1. This study is not a trial of HBOT but rather a trial of intratympanic steroid&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; 2. Methods do not describe the randomisation process or if blinded&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; 3. Small sample groups limit the generalisation of the study&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; 4. Post-hoc subgroup analysis suggests the profoundly deaf subgroup had better recover with the addition of intra-tympanic steroids. &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;5. All patients had an MRI to exclude space occupying lesions. &amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;6. Siegel’s criteria define complete recovery as an improvement of at least 25dB&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt;'''Appraised by:''' Dr Katherine Witheridge Department of Diving and Hyperbaric Medicine Prince of Wales Hospital ; Friday, 4 May 2018&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; Email: katherine.witheridge@health.nsw.gov.au&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size: 120%;&amp;quot;&amp;gt; '''Kill or Update By:''' June 2020&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:sumhorsa.gif|center]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;display: block; text-align: center;&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;font-size: 29.9px;&amp;quot;&amp;gt;[[Audiovestibular  |  BACK]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;/div&gt;</summary>
		<author><name>Gordoben</name></author>
		
	</entry>
</feed>